Clinical data | |
---|---|
Other names | ISF-2123 |
Routes of administration | Oral |
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C8H15N5O |
Molar mass | 197.242 g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
|
Pildralazine (Atensil), also known as propyldazine or propildazine, is an antihypertensive and vasodilator.
Synthesis
The reaction between 3,6-Dichloropyridazine (1) and 1-(Methylamino)-2-propanol (2) gives CID:12237595 (3). Reaction with hydrazine completes the synthesis of Pidralazine (4).
References
- Ganellin CR, Triggle DJ, Macdonald F (1997). Dictionary of pharmacological agents. CRC Press. p. 1603. ISBN 978-0-412-46630-4. Retrieved 25 November 2011.
- Pifferi G, Parravicini F, Carpi C, Dorigotti L (July 1975). "Synthesis and antihypertensive properties of new 3-hydrazinopyridazine derivatives". Journal of Medicinal Chemistry. 18 (7): 741–746. doi:10.1021/jm00241a020. PMID 1151996.
- DE2154245 idem G Pifferi, U.S. patent 3,769,278 (1973 to Isf Spa).
Nonsympatholytic vasodilatory antihypertensives (C02) | |
---|---|
Nitrovasodilator (arterioles and venules) | |
Hydrazinophthalazines (arterioles) | |
Potassium channel openers (arterioles) | |
Calcium channel blockers (arterioles) |
|
|